Millennium Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,749
Closed -$132K 5128
2023
Q2
$132K Sell
10,749
-29,455
-73% -$362K ﹤0.01% 3818
2023
Q1
$494K Buy
40,204
+23,219
+137% +$285K ﹤0.01% 3432
2022
Q4
$195K Buy
+16,985
New +$195K ﹤0.01% 4115
2021
Q3
Sell
-11,187
Closed -$71K 6101
2021
Q2
$71K Sell
11,187
-1,105
-9% -$7.01K ﹤0.01% 4876
2021
Q1
$77K Buy
+12,292
New +$77K ﹤0.01% 4339
2019
Q2
Sell
-13,349
Closed -$73K 4036
2019
Q1
$73K Sell
13,349
-22,473
-63% -$123K ﹤0.01% 3340
2018
Q4
$109K Sell
35,822
-134,047
-79% -$408K ﹤0.01% 3144
2018
Q3
$712K Sell
169,869
-47,353
-22% -$198K ﹤0.01% 2702
2018
Q2
$839K Buy
217,222
+50,080
+30% +$193K ﹤0.01% 2596
2018
Q1
$1.06M Sell
167,142
-92,861
-36% -$588K ﹤0.01% 2460
2017
Q4
$2.1M Buy
260,003
+178,660
+220% +$1.44M ﹤0.01% 2094
2017
Q3
$931K Sell
81,343
-27,991
-26% -$320K ﹤0.01% 2332
2017
Q2
$1.07M Buy
109,334
+54,998
+101% +$537K ﹤0.01% 2206
2017
Q1
$1.32M Buy
54,336
+38,528
+244% +$934K ﹤0.01% 2037
2016
Q4
$507K Sell
15,808
-232,076
-94% -$7.44M ﹤0.01% 2466
2016
Q3
$12.4M Sell
247,884
-12,229
-5% -$611K 0.02% 766
2016
Q2
$11M Buy
+260,113
New +$11M 0.03% 762
2016
Q1
Sell
-180,138
Closed -$11.2M 3554
2015
Q4
$11.2M Buy
+180,138
New +$11.2M 0.02% 836
2015
Q3
Sell
-32,983
Closed -$3.21M 3636
2015
Q2
$3.21M Sell
32,983
-80,455
-71% -$7.83M 0.01% 1519
2015
Q1
$10.6M Sell
113,438
-115,068
-50% -$10.8M 0.02% 928
2014
Q4
$20.3M Sell
228,506
-24,578
-10% -$2.19M 0.04% 574
2014
Q3
$17.5M Sell
253,084
-8,182
-3% -$565K 0.04% 534
2014
Q2
$15M Buy
261,266
+222,134
+568% +$12.7M 0.04% 577
2014
Q1
$1.55M Buy
39,132
+14,265
+57% +$566K ﹤0.01% 1618
2013
Q4
$1.04M Buy
24,867
+731
+3% +$30.7K ﹤0.01% 1813
2013
Q3
$720K Buy
24,136
+21,264
+740% +$634K ﹤0.01% 1837
2013
Q2
$152K Buy
+2,872
New +$152K ﹤0.01% 2345